Evidence map›Paper›PMID 38812771›Full record

ReviewLung cancer management2024

Prognostic significance of systemic immune inflammatory index in NSCLC: a meta-analysis.

Wen-Hua Chen, Jing-Jing Shao, Ying Yang, Yun Meng, Sheng Huang, Rong-Fang Xu, Ji-Bin Liu, Jian-Guo Chen, Qin Wang, Hai-Zhen Chen

Abstract readReview
In one paragraph

Review in Lung cancer management, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wen-Hua ChenMedical School of Nantong University, Nantong, 226000, China.ORCID https://orcid.org/0000-0003-4639-0908
Jing-Jing ShaoCancer Institute, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000, China.
Ying YangCancer Institute, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000, China.
Yun MengDepartment of Oncology, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000,China.
Sheng HuangDepartment of Oncology, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000,China.
Rong-Fang XuDepartment of Oncology, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000,China.
Ji-Bin LiuCancer Institute, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000, China.
Jian-Guo ChenCancer Institute, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000, China.
Qin WangCancer Institute, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226000, China.
Hai-Zhen ChenMedical School of Nantong University, Nantong, 226000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

baselinemeta-analysisNSCLCprognosissystemic immune inflammation index (SII)

Identifiers

PMID38812771
PMCPMC11131347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.